Access cutting-edge follicular lymphoma treatment through this clinical trial at a research site in Newark. Study-provided care at no cost to qualified participants.
Access follicular lymphoma specialists in Newark at no cost
This study follows strict safety protocols and ethical guidelines
All study-related follicular lymphoma treatment provided free
Follicular lymphoma (FL) is the second most common B-cell cancer and the most common type of cancer of lymphocytes. Unfortunately, this disease is incurable with conventional treatment and the disease recurs in almost all patients. This study will assess how safe and effective epcoritamab is in combination with lenalidomide and rituximab (R2) in treating adult participants with previously untreated FL. Adverse events and change in disease condition will be assessed. Epcoritamab is an investigat
Sponsor: Genmab
Check if you qualify for this follicular lymphoma clinical trial in Newark, DE
If you're searching for follicular lymphoma treatment options in Newark, DE, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Newark research site is actively enrolling participants for this clinical trial. You'll receive care from experienced follicular lymphoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.